Trials / Unknown
UnknownNCT03385434
Evaluation of Endorings-2-assisted Colonoscopy: a New Accessory for Improvement of Adenoma Detection Rate?
- Status
- Unknown
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 292 (estimated)
- Sponsor
- University Hospital Muenster · Academic / Other
- Sex
- All
- Age
- 18 Years – 99 Years
- Healthy volunteers
- Accepted
Summary
Screening colonoscopy for colorectal cancer is essential to diagnose and remove adenomas, precancerous stages of colorectal cancer. Unfortunately approximately 25 % of all adenomas are missed during the examination. Recently a new colonoscopy accessory, the Endorings-2 (EndoAid Ltd., Casearea, Israel), has been designed to improved the detection of adenomas during colonoscopy (adenoma detection rate). Endorings-2 is a silicone-rubber device that is fitted on the colonoscope and is equipped with circular flexible silicon rings mechanically stretching the colonic folds during withdrawal. This study aims to evaluate the efficacy of Endorings-2 to improve the adenoma detection rate in a prospective, blinded clinical trial. 292 patients with an indication for a screening colonoscopy shall be included (1:1 randomization in standard colonoscopy versus Endorings-2-assisted colonoscopy).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | Endorings-2 | 292 patients with an indication for screening colonoscopy will be included. 146 patients will receive a standard colonoscopy and 146 patients will receive an Endorings-2 assisted colonoscopy (1:1 standard colonoscopy vs Endorings-2-assisted colonoscopy). |
Timeline
- Start date
- 2018-02-01
- Primary completion
- 2021-08-30
- Completion
- 2022-02-01
- First posted
- 2017-12-28
- Last updated
- 2020-06-16
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT03385434. Inclusion in this directory is not an endorsement.